Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerReferences
Parkin DM, Kramárová E, Draper GJ, et al. International incidence of childhood cancer: volume 2. In: Parkin DM, Kramárová E, Draper GJ, et al., editors. Lyon: IARC; 1998.
Smith MA, Gurney JG, Gloeckler Ries LA. Cancer among adolescents 15–19 years old. In: Gloeckler Ries LA, Smith MA, Gurney JG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda,MD: NIH Pub No 99-4649; 1999, p. 157–164.
World Health Organization. Pathology and genetics. tumours of soft tissue and bone. Fletcher CDM, Unni KK, Mertens F, editors. Lyon: IARC Press; 2002.
- Epidemiology of childhood cancer.IARC, Lyon1999
- Epidemiology and genetics of childhood cancer.Oncogene. 2004; 23: 6429-6444
- International variations in the incidence of childhood bone tumours.Int J Cancer. 1993; 53: 371-376
- Population-based genetic alterations in Ewing’s tumors from Japanese and European caucasian patients.Ann Oncol. 2002; 13: 1656-1664
- Hernias and Ewing’s sarcoma family of tumours: a pooled analysis and meta-analysis.Lancet Oncol. 2005; 6: 485-490
- Parental occupation and Ewing’s sarcoma: Pooled and meta-analysis.Int J Cancer. 2005; 115: 799-806
- Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study.Lancet. 2004; 364: 2097-2105
- The international classification of childhood cancer.Int J Cancer. 1996; 68: 759-765
- Kirkwood B.R. Sterne A.C. Essential medical statistics. Blackwell Science Ltd, Oxford2003
Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda,MD: NIH Pub No 99-4649; 1999, p. 99–110.
- Incidence of malignant disease by morphological type, in young persons aged 12–24 years in England, 1979–1997.Eur J Cancer. 2003; 39: 2622-2631
- Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.J Clin Oncol. 2002; 20: 776-790
- Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group.J Clin Oncol. 2000; 18: 3108-3114
- Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994.Br J Cancer. 2006; 94: 22-29
Paulussen M, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc ASCO 2003, Abstract No. 3279.
- EUROCARE Working Group. Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study.Eur J Cancer. 2001; 37: 760-766
- Childhood cancer survival in Europe.Ann Oncol. 2003; 14: v119-v127
- Cancer survival in European adolescents and young adults.Eur J Cancer. 2003; 39: 2600-2610
- Survival of Ewing’s sarcoma patients in Hungary.Hungarian Oncol. 2000; 44: 261-264
- Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.Acta Orthop Scand (Suppl). 2004; 75: 92-98
- Ewing’s sarcoma treatment in Scandinavia 1984-1990: ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.Acta Oncol. 1998; 37: 375-378
- Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials.Int J Radiol Oncol Biol Phys. 2003; 55: 168-177
- Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.Eur J Cancer. 2005; 41: 2836-2845
- Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.J Clin Oncol. 2000; 18: 4-11
Medical Research Council working party on bone sarcoma. A trial of chemotherapy in patients with osteosarcoma. (A report to the Medical Research Council by theor Working Party on Bone Sarcoma). Br J Cancer 1986;53:513–18.
- A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.J Clin Oncol. 1992; 10: 1579-1591
- Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.Lancet. 1997; 350: 911-917
- Long-term results from the first UKCCSG Ewing’s Tumour Study (ET-1).Eur J Cancer. 1997; 33: 1061-1069
- Ifosfamide-containing chemotherapy in Ewing’s sarcoma: the second United Kingdom childrens’s cancer study group and the medical research council Ewing’s tumor study.J Clin Oncol. 1998; 16: 3628-3633
- Challenges in the management of bone tumors–1996.Ann N Y Acad Sci. 1997; 824: 167-179
- Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.Med Pediatr Oncol. 2003; 40: 276-287